Hollibaugh Ryan, Yu Xueliang, De Brabander Jef K
Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9038, United States.
Tetrahedron. 2020 Dec 4;79(4). doi: 10.1016/j.tet.2020.131673. Epub 2020 Oct 12.
Efficient approaches that enable the synthesis of analogs of natural product antibiotics are needed to keep up with the emergence of multiply-resistant strains of pathogenic organisms. One promising candidate in this area is fidaxomicin, which boasts impressive anti-tubercular activity but has poor systemic bioavailability. We designed a flexible synthetic route to this target to enable the exploration of new chemical space and the future development of analogs with superior pharmacokinetics. We developed a robust approach to each of the key macrocyclic and sugar fragments, their union via stereoselective glycosylation, and a convergent late-stage macrolide formation with fully glycosylated fragments. Although we were able to demonstrate that the final Suzuki cross-coupling and ring-closing metathesis steps enabled macrocycle formation in the presence of the northern resorcylic rhamnoside and southern novioside sugars, these final steps were hampered by poor yields and the formation of the unwanted -macrocycle as the major stereoisomer.
为了跟上致病生物多重耐药菌株的出现,需要有能够合成天然产物抗生素类似物的有效方法。在这一领域,一个有前景的候选药物是非达霉素,它具有令人印象深刻的抗结核活性,但全身生物利用度较差。我们设计了一条通往该目标的灵活合成路线,以探索新的化学空间,并为具有更优药代动力学的类似物的未来开发创造条件。我们开发了一种稳健的方法来合成每个关键的大环和糖片段,通过立体选择性糖基化将它们结合起来,并与完全糖基化的片段进行汇聚式后期大环内酯形成反应。尽管我们能够证明最后的铃木交叉偶联和闭环复分解步骤能够在北部间苯二酚鼠李糖苷和南部新霉素糖存在的情况下实现大环的形成,但这些最后步骤受到产率低下以及形成不需要的β-大环作为主要立体异构体的阻碍。